Guar Gum 수출 진단 (PURIX Science)

Tridge 데이터와 무관한 제품·시장 본질 적합도

Confirmed: Canada’s official framework requires food additives to be on Health Canada’s permitted lists, and CFIA states that most foods imported into Canada require a Safe Food for Canadians licence; the EU additive database confirms food-additive approvals are governed by Annex II of Regulation (EC) No 1333/2008. Confirmed therefore that food-grade guar gum is not a simple generic commodity sale in these markets and must be positioned by end-use and compliance status. Not fully confirmed in this run: exact tariff rates by HS code and destination, the current Russia/EAEU route for guar gum across food and industrial uses, Australia’s exact AICIS treatment for guar gum, and market-level public demand figures robust enough to cite.

수출 난이도 (규제·무역·인증)

Guar gum is exportable, but cross-sector execution is materially different by end-use. For food uses, the key challenge is additive-status compliance in each market: Canada requires alignment with Health Canada’s permitted food additive framework and the importer’s Safe Food for Canadians licence, while Italy follows the EU food-additives regime under Regulation (EC) No 1333/2008 and the UK applies its own retained/derived food-additives rules. For pharma, buyer qualification is usually tougher than customs clearance because customers often require GMP-oriented documentation, validated specifications, and supplier audits. For oil & gas and textile applications, industrial-chemical compliance, SDS/labeling, and powder handling matter more than food law; Australia’s AICIS treatment and Russia/EAEU registration path could not be fully verified within this research budget. I could not reliably verify destination-specific tariffs, Russia sanctions/payment practicality, or the exact current registration route for every non-food end-use, so those should be checked before pitching regulated applications aggressively.

시장 특성

구매자 우위 시장

특이사항

This is a multi-universe product: food, pharma, textile, and oilfield buyers will evaluate it on different specifications, so a single undifferentiated campaign risks weak conversion. Buyer power is usually high because industrial importers can compare viscosity, purity, hydration profile, mesh, microbiological limits, documentation quality, and consistency across multiple qualified origins/suppliers. Russia adds extra execution risk around sanctions, banking/logistics, and regulatory practicality even if demand exists. For food and pharma, documentation discipline and audit readiness can matter as much as price.

Pool → Targeted(20%) → Responded → Lead funnel. Responded·Lead는 본질 난이도 가중(low ×1.2 · moderate ×1.0 · high ×0.7). 최종 적합도는 Lead 범위 기준. Pool은 현재 매칭 기준 최소치이며 추가 발굴이 가능합니다(+).

Tridge’s discoverable reach is broad in raw pool terms across multiple universes, but the delivery outlook should be judged on the funnel-adjusted Lead band rather than the pool. On the total pool of 27156 buyers, the expected outcome is leads of 1.2~7.1 in the conservative scenario and 7.1~25.0 in the aggressive scenario, which supports a moderate—not high—delivery verdict because the realistic floor remains limited despite meaningful upside. The strongest upside sits in the larger pharma and Russia/UK/Italy universes, while high-difficulty weighting materially suppresses conversion in Australia, pharma, and Russia. This creates a clear gap versus axis ①: intrinsic market fit is high, but once regulatory friction, qualification burden, and funnel loss are applied, the realistic deal yield is narrower than the raw buyer pool suggests.

AI 리서치 기반 회사 수출 역량 진단 — 관측 무역 데이터는 참고 지표 (특정 제품/시장 적합성은 아래 별도 표시)

무역 데이터 미매칭 — 진술 정보 기반 평가

Web research produced only a very thin public footprint: the clearest signal found was a LinkedIn result indicating a Managing Director at PURIX Science in Vadodara, while I could not verify a company website, export organization, overseas offices, certifications, trade-fair activity, or documented foreign customer relationships from public sources. The reference trade data provides no matched customs record, which is not proof of no exports; Tridge에서 관측된 수출 데이터가 없다는 가정 하의 진단이며, 이는 실제로 수출한 적이 없다는 의미가 아니라 관측 커버리지 밖 수출이 존재할 수 있어 실제와 차이가 있을 수 있다. Applying the skeptical standard, a claim of current exports by itself is not enough to show a systematized direct-export capability, because there is no corroborating evidence of structured overseas sales operations or repeated direct market development. On that basis, the company is best assessed as having low demonstrated direct export capability at this stage.

캠페인 가격 · 커밋 Lead

결정론적 산정 — AI가 아닌 시스템 룰

확약 = min(4축 점수 밴드, pool 이행 상한). 4축 = 제품·시장 적합도(high 3 · moderate 2 · low 0) + 수출 난이도(low 3 · moderate 2 · high 0) + 판매자 경쟁력(high 2 · moderate 1 · low 0 · 미제공 1) + Tridge 데이터 준비도(±1). 밴드 8+→5 · 6~7→4 · 4~5→3 · 2~3→2 · 그 외 1. 상한은 보수·공격 시나리오 Lead 상한의 중간값(중복 제거 union pool 기준). 커밋 0개는 판매 비권고에서만.

Tridge 데이터 준비도: 발굴 pool 중 수입 실적이 확인되는 비율 44.7% — 나머지는 이름·설명 매칭만으로 잡힌 미검증 회사다.

The committed qualified-lead count is 3 because the fixed 4-axis capability score was 4, which maps to a target of 3건, while the pool-based delivery cap from the 발굴 pool 19124개 was 5건; the lower value becomes the commitment. The number was therefore held down by the grade side rather than by the pool cap. Within the score, 제품·시장 적합도 high contributed +3 and Tridge 데이터 준비도 44.7% contributed +1, while 수출 난이도 high and 판매자 수출 경쟁력 low did not add points, which is why the target stayed at 3 rather than rising to the cap.